Economic evaluation of brief cognitive behavioural therapy for social activation in recent-onset psychosis

firemonkey · November 13, 2018, 3:52pm

ncbi.nlm.nih.gov

Economic evaluation of brief cognitive behavioural therapy for social activation in recent-onset psychosis.

BFM Wijnen, K Pos, E Velthorst, F Schirmbeck, HY Chan, L de Haan, M van der Gaag, SMAA Evers and F Smit, PloS one, 2018

In schizophrenia spectrum disorders, negative symptoms (e.g. social withdrawal) may persist after initial treatment with antipsychotics, much affecting the quality of life (QOL) of patients. This health-economic study evaluated if a dedicated form of cognitive behaviour therapy for social activation (CBTsa) would reduce negative symptoms and improve QOL in an economically sustainable way.A health-economic evaluation was conducted alongside a single-blind randomised controlled trial in two parallel groups: guideline congruent treatment as usual (TAU; n = 50) versus TAU augmented with adjunct CBTsa (n = 49). Outcomes were PANSS negative symptom severity and EQ-5D quality adjusted life years (QALYs) gained. The health-economic evaluation was conducted both from the societal and the health sector perspective.Both conditions showed improvement in the respective outcomes over the follow-up period of six months, but QALY gains were significantly higher in the CBTsa condition compared to the TAU condition. Treatment response rate (i.e. ≥ 5-point decrease on the PANSS) was not significantly different. However, the add-on CBT intervention was associated with higher costs. This did not support the idea that CBTsa is a cost-effective adjunct. Various sensitivity analyses attested to the robustness of these findings.In the Dutch context where TAU for psychosis is guideline congruent and well implemented there appears no added value for adjunct CBTsa. In other settings where the treatment for the schizophrenia spectrum disorders solely relies on antipsychotics, add-on CBTsa may lead to clinically superior outcomes, but it should still be evaluated if adjunct CBTsa therapy is a cost-effective alternative.ClinicalTrials.gov registry under NCT03217955.

twinklestars · November 13, 2018, 4:17pm

Well that’s too bad, but I did want to add that CBT and cognitive remediation aren’t the same therapy.

NutsAboutU · November 13, 2018, 4:37pm

‘Improving Functioning in Schizophrenia’ - Brain and Behaviour Research Foundation

Topic		Replies	Views
Cognitive Behavioural Therapy for Psychosis: A Health Technology Assessment News	3	350	November 19, 2018
CBT for schizophrenia: a critical viewpoint News	3	454	February 13, 2019
Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial News	0	332	July 10, 2018
Comparison of the Effectiveness of Two Cognitive-Behavioral Group Therapy Programs for Schizophrenia: Results of a Short-Term Randomized Control Trial News	1	246	August 31, 2019
CBT for Psychosis - Selfhelp in Busy Clinics Possible, Suggests Latest Research Study News	2	1917	May 23, 2016

Economic evaluation of brief cognitive behavioural therapy for social activation in recent-onset psychosis

Related topics